Vitamin a is a negative regulator of osteoblast mineralization.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3858291)

Published in PLoS One on December 10, 2013

Authors

Thomas Lind1, Anders Sundqvist, Lijuan Hu, Gunnar Pejler, Göran Andersson, Annica Jacobson, Håkan Melhus

Author Affiliations

1: Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala University, Uppsala, Sweden.

Articles cited by this

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27

Matrix-embedded cells control osteoclast formation. Nat Med (2011) 5.77

Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66

Serum retinol levels and the risk of fracture. N Engl J Med (2003) 3.29

Vitamin A intake and hip fractures among postmenopausal women. JAMA (2002) 2.90

Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet (2008) 2.82

Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science (2006) 2.70

Vitamin A transport in human vitamin A toxicity. N Engl J Med (1976) 2.29

Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev Cell (2004) 2.07

Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91

Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J (2011) 1.74

Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol (2002) 1.58

Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development (2008) 1.42

Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res (2011) 1.35

Individual osteoblasts in the developing calvaria express different gene repertoires. Bone (2001) 1.17

Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization. J Cell Biol (2002) 1.16

Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. Am J Hum Genet (2011) 1.12

Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology (1996) 1.12

Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res (2002) 1.11

Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development. Development (2008) 1.11

Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem (2001) 1.10

Retinoic acid induces rapid mineralization and expression of mineralization-related genes in chondrocytes. Exp Cell Res (1993) 1.09

A paradoxical teratogenic mechanism for retinoic acid. Proc Natl Acad Sci U S A (2012) 1.08

Functions of vitamin D, retinoic acid, and dexamethasone in mouse adipose-derived mesenchymal cells. Tissue Eng (2006) 1.06

BMP action in skeletogenesis involves attenuation of retinoid signaling. J Cell Biol (2006) 1.05

Three isolation techniques for primary culture of human osteoblast-like cells: a comparison. Acta Orthop Scand (1999) 1.04

Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc Natl Acad Sci U S A (2010) 1.02

CCAAT/Enhancer binding protein beta abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 transcription. Mol Endocrinol (2007) 1.01

CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation. J Cell Biol (2008) 1.00

The mature osteoblast phenotype is characterized by extensive plasticity. Exp Cell Res (1997) 0.99

Translational regulation is a control point in RUNX2/Cbfa1 gene expression. Biochem Biophys Res Commun (2001) 0.99

Hypervitaminosis A and bone. Nutr Rev (2000) 0.98

Genetic disruption of CYP26B1 severely affects development of neural crest derived head structures, but does not compromise hindbrain patterning. Dev Dyn (2009) 0.98

Vitamin A inhibits chondrogenesis but not myogenesis. Exp Cell Res (1980) 0.96

Vitamin a metabolism, action, and role in skeletal homeostasis. Endocr Rev (2013) 0.96

Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice. Mol Endocrinol (2012) 0.91

Retinoic acid is a major regulator of chondrocyte maturation and matrix mineralization. Microsc Res Tech (1994) 0.90

Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK. PLoS One (2010) 0.89

Osteoblastic differentiation of monkey embryonic stem cells in vitro. Cloning Stem Cells (2005) 0.89

Subclinical hypervitaminosis A causes fragile bones in rats. Bone (2002) 0.88

High-dose retinoic acid modulates rat calvarial osteoblast biology. J Cell Physiol (2005) 0.88

Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. Tissue Eng (2007) 0.88

Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. Biochem Biophys Res Commun (2004) 0.87

Expression of the retinoic acid catabolising enzyme CYP26B1 in the chick embryo and its regulation by retinoic acid. Gene Expr Patterns (2003) 0.86

Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents. Bone (2005) 0.86

Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosis. Plast Reconstr Surg (2010) 0.85

The pathogenesis of retinoic acid-induced vertebral abnormalities in golden Syrian hamster fetuses. Teratology (1983) 0.85

High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats. Bone (2010) 0.84

Examination of nuclear receptor expression in osteoblasts reveals Rorβ as an important regulator of osteogenesis. J Bone Miner Res (2012) 0.83

Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin. PLoS One (2013) 0.83

Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice. Bone (2008) 0.82

Retinol deprivation partially rescues the skeletal mineralization defects of Phex-deficient Hyp mice. Bone (2012) 0.82

Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol (1998) 0.80

Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro. Eur J Endocrinol (1995) 0.80

Retinoic acid suppresses the osteogenic differentiation capacity of murine osteoblast-like 3/A/1D-1M cell cultures. Differentiation (1998) 0.80

Reverse transcription-polymerase chain reaction assay demonstrates that the 9-cis retinoic acid receptor alpha is expressed in human osteoblasts. Biochem Biophys Res Commun (1993) 0.80

A novel model of in vitro osteocytogenesis induced by retinoic acid treatment. Eur Cell Mater (2012) 0.80

Phase-independent inhibition by retinoic acid of mineralization correlated with loss of tetranectin expression in a human osteoblastic cell line. Cell Struct Funct (2001) 0.78

All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO. Cell Struct Funct (1997) 0.78

Stimulation by retinoids of the natriuretic peptide system of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun (1996) 0.76

Articles by these authors

Efficient mapping of mendelian traits in dogs through genome-wide association. Nat Genet (2007) 5.99

A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature (2003) 5.41

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med (2009) 3.83

Serum retinol levels and the risk of fracture. N Engl J Med (2003) 3.29

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation (2009) 2.85

Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ (2009) 2.79

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73

Mast cells can enhance resistance to snake and honeybee venoms. Science (2006) 2.72

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis (2009) 2.70

Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69

Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. J Am Soc Nephrol (2012) 2.48

Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs. Nat Genet (2007) 2.33

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ (2013) 2.17

Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis (2009) 1.97

Genetic liability to fractures in the elderly. Arch Intern Med (2005) 1.88

Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep (2008) 1.84

Mechanism of hypoxia-induced NF-kappaB. Mol Cell Biol (2010) 1.74

A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem (2004) 1.70

Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis. PLoS Genet (2013) 1.69

Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol (2007) 1.66

Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol (2008) 1.65

Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr (2010) 1.64

ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth. PLoS Biol (2009) 1.61

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens (2002) 1.55

Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ (2011) 1.53

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics (2003) 1.52

Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat Genet (2010) 1.49

Determining vitamin D status: a comparison between commercially available assays. PLoS One (2010) 1.49

Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med (2009) 1.48

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment. J Hypertens (2004) 1.45

Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation (2009) 1.43

Leisure physical activity and the risk of fracture in men. PLoS Med (2007) 1.41

The positive effect of dietary vitamin D intake on bone mineral density in men is modulated by the polyadenosine repeat polymorphism of the vitamin D receptor. Bone (2006) 1.39

[Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy]. Lakartidningen (2003) 1.39

Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res (2004) 1.36

Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci U S A (2009) 1.34

The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J Exp Med (2003) 1.34

Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem (2004) 1.32

Intracellular proteoglycans. Biochem J (2004) 1.25

Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One (2009) 1.25

Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med (2008) 1.23

A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation. Blood (2010) 1.20

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial. PLoS One (2013) 1.18

Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood (2007) 1.16

Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest (2011) 1.16

Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res (2004) 1.15

Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. J Immunol (2009) 1.15

Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14. Epilepsy Res (2002) 1.14

Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis (2003) 1.13

Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res (2002) 1.11

Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med (2004) 1.11

Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol (2011) 1.11

Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol. Free Radic Biol Med (2009) 1.11

Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem (2005) 1.09

Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab (2002) 1.08

Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs Quantitation of RNA expression in human tissues. J Virol Methods (2005) 1.08

Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone (2003) 1.07

Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol (2008) 1.07

Biology of mast cell tryptase. An inflammatory mediator. FEBS J (2006) 1.06

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition. J Cell Mol Med (2013) 1.06

Biological implications of preformed mast cell mediators. Cell Mol Life Sci (2010) 1.06

Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J Biol Chem (2004) 1.05

Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem (2005) 1.05

Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail (2010) 1.05

Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. J Biol Chem (2007) 1.04

Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J (2007) 1.03

Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J Biol Chem (2006) 1.02

Serglycin: the master of the mast cell. Methods Mol Biol (2012) 1.01

Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun (2010) 1.01

Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study. Nutr Metab (Lond) (2010) 0.99

Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab (2008) 0.99

Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. Bone (2007) 0.99

MHC class II polymorphism is associated with a canine SLE-related disease complex. Immunogenetics (2009) 0.99

Human mast cell beta-tryptase is a gelatinase. J Immunol (2003) 0.99

ZBED evolution: repeated utilization of DNA transposons as regulators of diverse host functions. PLoS One (2013) 0.98

Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol (2010) 0.97

Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study. BMC Cancer (2008) 0.97

Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem (2010) 0.96

Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res (2004) 0.96

Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. FASEB J (2008) 0.96

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. J Hypertens (2002) 0.95

Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity. J Biol Chem (2003) 0.95

The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol (2010) 0.95

ZBED6: The birth of a new transcription factor in the common ancestor of placental mammals. Transcription (2010) 0.94

Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. J Bone Miner Res (2006) 0.94

Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res (2009) 0.94

A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J (2006) 0.94

Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J Bone Miner Res (2011) 0.93

Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood (2007) 0.93

Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. J Cell Biochem (2005) 0.92

The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis. Am J Pathol (2012) 0.92

The first sequenced carnivore genome shows complex host-endogenous retrovirus relationships. PLoS One (2011) 0.92

Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med (2008) 0.92

Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS One (2008) 0.92

Mast cell proteoglycans. J Histochem Cytochem (2012) 0.92

Two loci on chromosome 5 are associated with serum IgE levels in Labrador retrievers. PLoS One (2012) 0.92

Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing. Biol Chem (2002) 0.91

Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. J Biol Chem (2002) 0.91